Other Issues

Browse Other Issues Content

Article

Find detailed information about each section of the CARES Act, which was passed in 2020 in response to the COVID-19 pandemic.

Mar 25, 2020

Submission

We strongly agree that healthcare product manufacturers have a central role to play in the fight against this pandemic. Provided employers comply with CDC guidelines to protect workers, healthcare product manufacturers have the special responsibility to maintain their current work schedules.

Mar 20, 2020

Article

CHPA continues to closely monitor the rapidly-evolving Coronavirus Disease 2019 (COVID-19) outbreak.

Mar 6, 2020

Submission

Enclosed are comments on “Transdermal and Topical Delivery Systems - Product Development and Quality Considerations”. CHPA and our member companies marketing external analgesic ingredients have an interest, experience, and expertise in this area and appreciate this opportunity to comment.

Feb 19, 2020

Press Releases and Statements

The four leading trade associations representing the dietary supplement industry are concerned that some marketers of dietary supplements may be promoting them with claims of prevention or treatment of Coronavirus.

Feb 11, 2020

Press Releases and Statements

Medical and patient groups, public health experts, FDA, and others join the Consumer Healthcare Products Association in opposing the addition of acetaminophen to the Proposition 65 list.

Jan 23, 2020

Press Releases and Statements

The observational Internet survey results pre-published in the American Journal of Gastroenterology reporting an association between use of proton-pump inhibitor (PPI) medicines and self-reported positive tests for COVID-19 among people taking PPIs do not prove cause-and-effect.

Jan 10, 2020

Press Releases and Statements

The 2019 results from the NIDA and University of Michigan’s annual drug abuse survey, Monitoring the Future, show that the number of teens using OTC cough medicine containing DXM to get high decreased slightly.

Dec 18, 2019

Filter Results